• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by EUDA Health Holdings Limited

    10/10/24 4:15:23 PM ET
    $EUDA
    Medical/Nursing Services
    Health Care
    Get the next $EUDA alert in real time by email
    6-K 1 form6-k.htm

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of October 2024

     

    Commission File Number: 001-40678

     

    EUDA Health Holdings Limited

    (Exact Name of Registrant as Specified in its Charter)

     

    1 Pemimpin Drive #12-06

    One Pemimpin Singapore 576151

    (Address of Principal Executive Offices and Zip Code)

    Registrant’s telephone number, including area code: +65 6268 6821

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

     

    Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

     

    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

     

    Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

     

     

     

     

     

     

    EUDA Health Holdings Limited (the “Company”) furnishes under the cover of Form 6-K of the following.

     

    Exhibits

     

    99.1 Audited Financial Statements of Fortress Cove Limited.
    99.2 Pro Forma Condensed Combined Financial Statements.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

     

    Dated: October 10, 2024    
       
      EUDA Health Holdings Limited
         
      By: /s/ Wei Wen Kelvin Chen
      Name: Wei Wen Kelvin Chen
      Title: Chief Executive Officer

     

     

    Get the next $EUDA alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $EUDA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $EUDA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by EUDA Health Holdings Limited

      SC 13G - EUDA Health Holdings Ltd (0001847846) (Subject)

      3/27/24 7:35:31 AM ET
      $EUDA
      Medical/Nursing Services
      Health Care

    $EUDA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia

      SINGAPORE, April 24, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited ("EUDA" or the "Company") (NASDAQ:EUDA), a Singapore-based property management services provider and a leading non-invasive healthcare provider in Singapore and Malaysia, today announced an update to the potential strategic partnership, previously announced in December 2024, with Guangdong Cell Biotech Co. Ltd. ("Guangdong Cell Biotech"). Guangdong Cell Biotech is a prominent player in stem cell therapies and regenerative medicine in China. It develops autologous cell treatments and tailored medicines for various disorders. Instead of the initially contemplated joint venture, the parties have adopted a commercial

      4/24/25 7:00:00 AM ET
      $EUDA
      Medical/Nursing Services
      Health Care
    • EUDA Holdings and Guangdong Cell Biotech Explore Potential Strategic Partnership to Advance Biotechnology Innovation

      -        Preliminary Discussions Underway to Establish a Joint Venture SINGAPORE, Dec. 16, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited ("EUDA" or the "Company") (NASDAQ:EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, today announced that it has entered into preliminary discussions with Guangdong Cell Biotech Co. Ltd. ("Guangdong Cell Biotech"), a prominent player in stem cell therapies and regenerative medicine, to form a joint venture. Guangdong Cell Biotech develops autologous cell treatments and tailored medicines for various disorders. This potential collaboration aims to leverage the complem

      12/16/24 5:00:00 PM ET
      $EUDA
      Medical/Nursing Services
      Health Care
    • NRx Pharmaceuticals added to Emerging Growth Conference 76 on October 31 and Update to Schedule

      MIAMI, Oct. 31, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces NRx Pharmaceuticals (NASDAQ:NRXP) will appear on the Emerging Growth Conference today in response to multiple requests and investor demand. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Jonathan Javitt, MD, MPH, Founder and Chairman will be discussing its first steps towards acquisition through its HOPE Therapeutics subsidiary of a national network of interventional psychiatry clinics focused on tr

      10/31/24 7:00:00 AM ET
      $CIA
      $EUDA
      $GOSS
      $LDTC
      Life Insurance
      Finance
      Medical/Nursing Services
      Health Care

    $EUDA
    SEC Filings

    See more
    • SEC Form 6-K filed by EUDA Health Holdings Limited

      6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

      6/2/25 8:00:09 AM ET
      $EUDA
      Medical/Nursing Services
      Health Care
    • SEC Form 20-F filed by EUDA Health Holdings Limited

      20-F - EUDA Health Holdings Ltd (0001847846) (Filer)

      4/29/25 2:28:41 PM ET
      $EUDA
      Medical/Nursing Services
      Health Care
    • SEC Form 6-K filed by EUDA Health Holdings Limited

      6-K - EUDA Health Holdings Ltd (0001847846) (Filer)

      4/24/25 4:05:23 PM ET
      $EUDA
      Medical/Nursing Services
      Health Care